title: [Pharmacological and clinical profile of golimumab (Simponi®)].
authors.affiliation: hfujii@its.jnj.com
authors.forename: Hideji
authors.initials: H
authors.lastname: Fujii
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Murakami
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Harada
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006207:Half-Life; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy; D051379:Mice; D011961:Receptors, Fc / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D011961:Receptors, Fc; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab